Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $24.6M | $23.8M | $13.9M | $128.4K | $280.5K | $575.5K | $1.3M |
| Gross profit | $0 | −$24.6M | −$23.8M | −$13.9M | −$128.4K | −$280.5K | −$575.5K | −$1.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $8.8M | $16.5M | $17.4M | $4.3M | $17.2M | $6.9M | $14.4M | $21.4M |
| Operating income | −$17.8M | −$24.6M | −$23.8M | −$13.9M | −$26.3M | −$17.1M | −$26.6M | −$33.3M |
| EBITDA | −$16.4M | −$24.1M | −$22.8M | −$3.1M | −$26.7M | −$17.2M | −$25.9M | −$32.9M |
| Net income | −$15.2M | −$25.8M | −$23.8M | −$13.2M | −$27.1M | −$17.3M | −$25.7M | −$34.2M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -214.02 | -328.76 | -212.74 | -93.57 | -65.49 | -17.60 | -18.80 | -21.08 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $6M | $-1.57 | $-1.57–$-1.57 | 1 |
| 2027 | $152200 | $-1.85 | $-1.85–$-1.85 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds NBSE.
No tracked institution reports a position in NBSE as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-06-15 | 1-for-20reverse |
| 2019-02-04 | 1-for-20reverse |
No one on the platform has traded NBSE yet.
| $956000 |
| — |
| NMTRQ9 Meters Biopharma, Inc. | $0.00 | +0.00% | $145 | — |
| ONCSQOncoSec Medical Incorporated | $0.00 | +0.00% | $596 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$BCTX $CLRB $NBSE $ONCT this guy @ZhaoSonsWealth was pumping the fuck out of TGL. Now GLMD? 😆 🤣 😂
View on StockTwits ↗$STKH - is a low floater about to pop! $RGC $NBSE
View on StockTwits ↗$BLMZ Adding here, what a jump, and it is still holding back, the recoil tomorrow should be amazing. Exciting times. 50% inside ownership. Give the below fella a follow, he has 50k followers and is spot on with his calls, im holding for $1. Doing well - $NBSE $STAF $JBDI
View on StockTwits ↗$BLMZ Lets get it in AH, potential news soon. YTD highs coming. ''BloomZ Inc. (BLMZ) appears to be in an uptrend based on recent price movement and market observations. A recent analysis by HASHInvests200 on TradingView noted a breakout from a consolidation period and a positive trend reversal, with BLMZ breaking its key resistance level. Additionally, BLMZ's stock price has shown a significant positive return year-to-date and over the past year compared to the S&P 500, further suggesting an uptrend. BLMZ recently broke out from a consolidation period, indicating a potential start of an uptrend. Positive Trend Reversal: Analysis suggests a positive trend reversal with increasing volume, signifying a shift in momentum towards the upside. Key Resistance Break: BLMZ broke its key resistance level, further solidifying the bullish outlook. Strong Return Performance: The stock has demonstrated strong returns year-to-date and over the past year, outperforming the S&P 500'' $HOLO $MLGO $NBSE
View on StockTwits ↗$BLMZ looking great today! Correction road back to 30 cents, or $1 with some PR. $LLAP $NBSE
View on StockTwits ↗$NBSE $LRHC - BLMZ big correction play, should see this get back to 30 cents without news. $1 potential here. BLMZ is my next pick $$$ Good luck.
View on StockTwits ↗$NBSE my holdings from many years ago got liquidated today $0.13 per share. Let's just call it 100% loss. Glad I didn't buy too much.
View on StockTwits ↗$NBSE NeuBase Therapeutics, Inc. (NASDAQ:NBSE): Exploring Strategic Alternatives Amidst Challenging Financials https://beyondspx.com/article/neubase-therapeutics-inc-nasdaq-nbse-exploring-strategic-alternatives-amidst-challenging-financials
View on StockTwits ↗$NBSE Somebdy tell me how i can sell this turd so i can report my losses
View on StockTwits ↗$NBSE NeuBase Therapeutics, Inc. (NASDAQ:NBSE): Exploring Strategic Alternatives Amidst Challenging Financials http://beyondspx.com/2024/08/05/neubase-therapeutics-inc-nasdaqnbse-exploring-strategic-alternatives-amidst-challenging-financials/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.